Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Financing › Details

ReViral–LCF Rothschild: investment, 201509 financing round Series A totalling $21m incl new + co-lead investor EdRIP

 

Period Period 2015-09-08
  Successor ReViral–Andera Partners: investment, 201808 financing round Series B totalling $55m incl existing + co-investor Andera Partners
Organisations Money taker ReViral Ltd.
  Group ReViral (Group)
  Money source Edmond de Rothschild Investment Partners (EdRIP)
  Today Andera Partners (FR)
  Group Andera Partners (FR)
Products Product sisunatovir (RV521)
  Product 2 venture capital
Person Person Wisniewski, Raphaël (Andera Partners 202110 formerly LCF Rothschild at Edmond de Rothschild Investment Partners)
     

   
Record changed: 2018-08-14

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for ReViral (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top